We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Mary Carter Andrues Arent Fox LLP

Results 1 to 5 of 5



The expanding use of the Federal False Claims Act to police trade and export compliance *

USA - April 15 2013
The US Government's $45 million settlement with the Japanese company Toyo Ink SC Holdings Co., Ltd. and its affiliates, including companies in New…

Co-authors: Paul Rigali, Kay C. Georgi .


Increasing government scrutiny of pharmaceutical executives *

USA - December 3 2010
The US Food and Drug Administration (FDA) and the US Department of Justice (DOJ) recently reinforced that pharmaceutical executives are in the government's target zone.

Co-authors: Paul Rigali, Larri A. Short .


DOJ issues third FCPA Opinion Procedure Release of 2010 *

USA - September 7 2010
On September 1, 2010, the Department of Justice (DOJ) released its third Foreign Corrupt Practices Act (FCPA) Opinion Procedure Release of 2010 (Opinion).

Co-authors: Andrew D. Kaizer, Amal U. Dave, Peter V. B. Unger, Mark S. Radke.


DOJ issues second FCPA Opinion procedure release of 2010 *

USA - July 28 2010
On July 16, 2010, the US Department of Justice (DOJ) issued its second Foreign Corrupt Practices Act (FCPA) Opinion Procedure Release of 2010 (Opinion).

Co-authors: Andrew D. Kaizer, Amal U. Dave, Peter V. B. Unger.


The United Kingdom’s Bribery Act 2010 *

USA - April 20 2010
On April 8, 2010, the UK Parliament passed the Bribery Act 2010 ("the Act").

Co-authors: Andrew D. Kaizer, Amy E. Salomon, Peter V. B. Unger.